Schreiner MediPharm begins mass production of Needle-Trap

Published: 29-Sep-2010
Packaging Drug Delivery Pharmaceutical

Offers protection against needlestick injuries

Schreiner MediPharm has begun mass production of Needle-Trap, its economical and safe solution that protects against needlestick injuries.

Needle-Trap consists of a syringe label with integrated needle protection that secures the blood-contaminated needle after injection, thus protecting healthcare professionals from needlestick injuries.

The German company says Needle-Trap’s compact design and easy integration into existing production processes means a low-cost investment and minimal space requirements for pharmaceutical manufacturers. The combination of a label and needle protection can be processed on conventional labelling equipment with only minor modifications at dispensing speeds of up to 400 units a minute.

Schreiner-MediPharm says Needle-Trap also reduces material and packaging requirements and is thus environmentally friendly.

  • Companies:
  • Schreiner MediPharm
See more

You may also like

Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

Read more
The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency

Trending Articles

  1. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic blood-brain barrier transporter approaches. The results also suggest strong support for therapeutically relevant clinical effects of semaglutide using MetP Pharma’s DDT
  2. AdvanCell partners with 48Hour Discovery on peptide-based lead-212 radiotherapeutic The pair will develop a novel peptide-based Lead-212 radiotherapeutic targeting a gastrointestinal cancer with significant unmet need, strengthening AdcanCell's pipeline of differentiated targeted alpha therapies
  3. New research suggests repurposed diabetic drug may help prostate cancer A class of medication called SGLT2 inhibitors, traditionally used for diabetes, may help slow prostate cancer progression in men receiving hormone treatment
  4. Astoriom acquires Precision Stability Storage, expanding sample management capabilities The acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America and offers reliable, compliant and accessible solutions to advance scientific discovery and product development
  5. PharmNovo enhances its board ahead of Phase II development The new board members bring complementary experience in drug development, clinical execution and partnering, supporting the company’s continued progress and dialogue with potential partners

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency
Packaging

FINAT award recognises pioneering product in “Innovation” category

At this year’s FINAT Label Competition, Schreiner Group impressed with its Smart Syringe Box from the Schreiner MediPharm business unit
Packaging

Schreiner MediPharm debuts new digital labels for clinical trials

The technology has the potential to replace conventional labels by electronic ones with digital displays in the future
Packaging

Innovative light protection labels for prefilled syringes showcased at Pharmapack 2025

Schreiner MediPharm presents new functional labels for light-sensitive substance
Packaging

Schreiner MediPharm develops protective label for light-sensitive ADC on behalf of WuXi XDC

The pharmaceutical labelling company developed a cover for a light/UV-sensitive ADC drug product contained in a vial on behalf of CRDMO WuXi
Packaging

Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Manufacturing

Schreiner MediPharm to present its product innovations at CPHI China

Focus on sustainability and novel active ingredients with Freeze-Light-Protect and Needle-Trap solutions
Subscribe now